AAIS
TMDX icon

ABN AMRO Investment Solutions’s Transmedics TMDX Stock Holding History

ABN AMRO Investment Solutions’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,732
Closed -$1.23M – 459
2024
Q4 		$1.23M Buy
19,732
+1,262
+7% +$117K 0.02% 289
2024
Q3 		$2.9M Sell
18,470
-2,218
-11% -$342K 0.05% 222
2024
Q2 		$3.12M Sell
20,688
-231
-1% -$27.7K 0.06% 207
2024
Q1 		$1.55M Hold
20,919
– – 0.03% 277
2023
Q4 		$1.65M Sell
20,919
-431
-2% -$26K 0.03% 273
2023
Q3 		$1.17M Buy
21,350
+12,801
+150% +$921K 0.02% 288
2023
Q2 		$718K Buy
8,549
+2,996
+54% +$229K 0.01% 309
2023
Q1 		$421K Buy
+5,553
New +$384K 0.01% 357

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ABN AMRO Investment Solutions's TMDX Position: Q1 2025 in Review

ABN AMRO Investment Solutions sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 19,732 shares — an estimated $1.23M sold.

ABN AMRO Investment Solutions first reported a position in TMDX in Q1 2023 and held it in 8 quarters. The position peaked at $3.12M in Q2 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • ABN AMRO Investment Solutions reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • ABN AMRO Investment Solutions sold 19,732 Transmedics shares in Q1 2025, an estimated $1.23M.
  • ABN AMRO Investment Solutions first reported a position in Transmedics in Q1 2023 and held it in 8 quarters.
  • ABN AMRO Investment Solutions's Transmedics position peaked at $3.12M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on ABN AMRO Investment Solutions's 13F filing for Q1 2025, filed 27 Aug 2025.